Description: SAGE THERAPEUTICS, ZULRESSO, and their respective logos, and SAGE CENTRAL are registered trademarks of Sage Therapeutics, Inc. ZURZUVAE is a trademark of Sage Therapeutics Inc. All other trademarks referenced herein are the property of their respective owners.
English Español ( Spanish ) English (GB) About the Program How to Qualify About Huntington’s Disease FAQ See if you may qualify The information you provide will be kept confidential. ? If you qualify and give your permission, your answers will be submitted to the program team, who will contact you to discuss your possible participation. The information you provide will only be used in association with your possible participation in the program. Please see our privacy policy for more information.
If you qualify and give your permission, your answers will be submitted to the program team, who will contact you to discuss your possible participation. The information you provide will only be used in association with your possible participation in the program. Please see our privacy policy for more information.
Learn about a clinical research program investigating cognitive function in those with Huntington’s disease (HD) – with the potential to help advance the future of HD treatment.